“…Moreover, n-3 PUFA are powerful hypocholesterolemic and hypotriglyceridemic agents (Nordoy, 1965 ;Peifer, 1966 ;Dyerberg et al, 1975 ;Harris et al, 1983 ;Fehily et al, 1983 ;Durand et al, 1985). When the diet is deficient in these n-3 PUFA, n-3 fatty acids are usually replaced by n-6 fatty acids or, more strictly speaking, most of the 22 : 6 n-3 is replaced by 22 : 5 n-6 (Galli et al, 1971(Galli et al, , 1974Cohen and Bernsohn, 1978 ;Tinoco et al, 1978 ;Menon and Dhopeshwarkar, 1981 ;Nouvelot et al, 1983a,b ;Bourre er al., 1984 ;Youyou et al, 19861. However, when this occurs, the physiological status is not normal, resulting in an attention of the electroretinogram (ERG) (Wheeler et al, 1975 ;Neuringer et al, 1984Neuringer et al, , 1986aNouvelot et al, 1985), higher neonatal mortality (Sinclair and.Crawford, 1973 ;Francois et al, 1980 ;Guesnet et al, 1986), decreased learning ability (Galli et al, 1975 ;Lamptey and Walker, 1978), changes in enzyme activities which may alter membrane physiology (Bernsohn and Spitz, 1974 ;Sun and Sun, 1974 ;McMurchie and Raison, 1979 ;Flier et al, 1985), and neurological disorders (Holman et al, 1982). Now, membrane structures, and particularly those of the nervous.system, develop intensely during the foetal period and lactation (Sinclair and Crawford, 1972 ;Crawford et al, 1981 ;Bourre, 1984 ;Menon and Dhopeshwarkar, 1982).…”